It's clear that the parties will not agree on stimulus until after the election. Some reported polls give the edge to the liberal tax and spend democrats. Corona is once again surging all over the world. The deaths percentages are down, but renewed fear that the hospitals are once again becoming full with C19 patients causes lock down and hurts the economy.
Such uncertainty, fear and "the Biden effect" is having a recent negative effect on the stock market.
Stock Talk
The market and the mismanaged FDA and Operation Warp Speed (ows) team along with short sellers have had a recent bad effect of sp to some companies that are working to help bring an end to the C19 pandemic. Yet even still, two companies stand out in my view as having a chance to overcome challenges and may yet deliver a safer vaccine and treatment for C19.
Inovio (INO) - INO4800 DNA vaccine is on hold while the FDA is reportedly looking into "questions" on the cellectra device to administer the vaccine. Inovio has a pipeline of clinical trials for cancer treatments using the same type of device and an EUA approval for a similar SARS virus (mers) as C19. To many observers, the FDA hold of INO4800 on "questions" in a Pandemic seems like either mismanagement of power or corruption with Big Pharma involved.
Sorrento (SRNE) - has FDA cleared trials for giving C19 patients an antibody dose of CoviGuard (STI1499) at Temple hospital in Philadelphia. Trials on additional refinements (eg, STI 2020) are starting as well. Other products are in the works such as for testing.
These two stocks have been under siege by shorts because in Inovio case, the FDA put a hold on the device although no serious adverse effects have been reported.
In Sorrento's case , the shorts have attacked the sp because the company is pursing a broad line of products to address C19 and bigger things such as lung cancer (STI5656), but the regulatory process takes time.
While the two companies are working through regulatory process, the shorts have pounced upon the stocks. This keeps these two stocks in the speculative category. However, I suspect there is a fair chance things may turn around if, for example, Inovio is cleared to start P2/3 of INO4800 and if Sorrento shows positive results with C19 patients in Philadelphia Temple hospital.
While I consider the above two stocks specs they are quite interesting to watch.
One stock that looks to be a fair investment to sustain sp on metals is Yamana Gold (AUY) on Gold, silver and Copper. I hold some shares of AUY and may buy more on dips. Yamana is projecting higher production and is increasing the dividend. Those are two fundamentals that appeal to me. With ev's coming on- copper will be in demand.
ALL in my humble opinion, scroll down and read more..This site does NOT make Buy / Sell recommendations.
___
